Establishing an Automated High-throughput Assay That Supports the Growth of Prostate Cancer Organoid
Establishing an Automated High-throughput Assay That Supports the Growth of Prostate Cancer Organoid
2 PagesProstate cancer is one of the leading causes of cancer-related deaths in men, second only to lung cancer.1 The standard of care for patients diagnosed with advanced and metastatic prostate cancer is androgen deprivation therapy (ADT), sometimes in combination with other androgen receptor (AR)-directed treatments or taxane-based chemotherapy.
